IP Library › Assignment 055357/0691

Patent Assignment

Reel/Frame 055357/0691

Release of Security Interest

Recorded: 2021-02-22 Pages: 21

View PDF Order Certified Copy

Assignor

INNOVATUS LIFE SCIENCES LENDING FUND I, LP

Executed: 2021-02-22

Assignee

BIOTHERANOSTICS, INC.

9640 TOWNE CENTER DR., SUITE 200, SAN DIEGO, CALIFORNIA, 92121

Covered Properties (41)

Identification of Tumors

PCT: PCT/US2005/019736 ↗

Identification of Tumors and Tissues

PCT: PCT/US2006/021471 ↗

Prostate Cancer Survival and Recurrence

PCT: PCT/US2008/054820 ↗

Tumor Grading and Cancer Prognosis

PCT: PCT/US2008/075528 ↗

Determining Tumor Origin

PCT: PCT/US2011/031870 ↗

Post-Treatment Breast Cancer Prognosis

PCT: PCT/US2011/064290 ↗

Neuroendocrine Tumors

PCT: PCT/US2014/031587 ↗

Predicting Breast Cancer Recurrence

PCT: PCT/US2014/055041 ↗

Predicting Likelihood of Response to Combination Therapy

PCT: PCT/US2015/033047 ↗

Integration of Tumor Characteristics with Breast Cancer Index

PCT: PCT/US2016/061568 ↗

Predicting Outcome with Tamoxifen in Breast Cancer

Patent: 7,504,214 →

Application: 10/727,100 →

Publication: US 2005/0239079

Predicting breast cancer treatment outcome

Patent: 9,856,533 →

Application: 10/773,761 →

Publication: US 2005/0239083

Identification of tumors

Application: 11/145,307 →

Publication: US 2006/0094035

Identification of Tumors and Tissues

Application: 11/422,056 →

Publication: US 2007/0020655

Grading of Breast Cancer

Patent: 7,930,105 →

Application: 11/946,835 →

Publication: US 2009/0092973

Prostate Cancer Survival and Recurrence

Application: 12/391,224 →

Publication: US 2010/0047787

Tumor Grading and Cancer Prognosis

Patent: 9,447,470 →

Application: 12/718,973 →

Publication: US 2011/0136680

Grading of Breast Cancer

Application: 13/083,500 →

Publication: US 2011/0183858

Identification of Tumors

Application: 13/626,078 →

Publication: US 2013/0023441

Post-Treatment Breast Cancer Prognosis

Application: 13/914,617 →

Publication: US 2013/0281502

Neuroendocrine Tumors

Application: 14/223,473 →

Publication: US 2014/0349856

Predicting Breast Cancer Recurrence

Application: 14/483,108 →

Publication: US 2015/0203921

Predicting Likelihood of Response to Combination Therapy

Patent: 10,253,369 →

Application: 14/724,732 →

Publication: US 2015/0344967

Determining Tumor Origin

Patent: 9,670,553 →

Application: 14/810,323 →

Publication: US 2015/0329921

Grading of Breast Cancer

Patent: 10,329,624 →

Application: 15/130,777 →

Publication: US 2017/0073767

Tumor Grading and Cancer Prognosis

Application: 15/242,346 →

Post-Treatment Breast Cancer Prognosis

Patent: 11,078,538 →

Application: 15/298,128 →

Publication: US 2017/0253931

Integration of Tumor Characteristics with Breast Cancer Index

Patent: 11,530,448 →

Application: 15/349,915 →

Publication: US 2017/0137891

Identification of Tumors

Patent: 10,538,816 →

Application: 15/368,411 →

Publication: US 2017/0268064

Identification of Tumors and Tissues

Patent: 11,430,544 →

Application: 15/368,446 →

Publication: US 2017/0286596

Prostate Cancer Survival and Recurrence

Application: 15/470,818 →

Publication: US 2018/0051342

Tumor Grading and Cancer Prognosis

Application: 15/473,472 →

Determining Tumor Origin

Application: 15/582,125 →

Publication: US 2018/0073085

Neuroendocrine Tumors

Patent: 11,549,148 →

Application: 15/656,998 →

Publication: US 2018/0135131

Tumor Grading and Cancer Prognosis

Patent: 11,021,754 →

Application: 15/807,456 →

Publication: US 2018/0291461

Predicting Breast Cancer Treatment Outcome

Application: 15/807,474 →

Publication: US 2018/0127834

Grading of Breast Cancer

Application: 16/404,424 →

Publication: US 2020/0095642

Identification of Tumors

Application: 16/701,000 →

Publication: US 2020/0190597

Predicting Breast Cancer Recurrence

Application: 61/876,757 →

Integration of Tumor Characteristics with Breast Cancer Index

Application: 62/255,260 →

Integration of Tumor Characteristics with Breast Cancer Index

Application: 62/265,964 →

Related Assignments (8)

Other recorded transfers of the patents in this record — the chain of ownership.

Security Interest Apr 22, 2019

From: BIOTHERANOSTICS, INC.

To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP

Reel/Frame 048960/0213 →

Security Interest Apr 5, 2021

From: BIOTHERANOSTICS, INC.

To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT

Reel/Frame 055818/0519 →

Assignment of Assignor's Interest Apr 12, 2021

From: SGROI, DENNIS

To: THE GENERAL HOSPITAL CORPORATION

Reel/Frame 055896/0513 →

Assignment of Assignor's Interest Apr 12, 2021

From: ERLANDER, MARK G.; MA, XIAO-JUN

To: BIOTHERANOSTICS, INC.

Reel/Frame 055896/0333 →

Assignment of Assignor's Interest Jun 21, 2021

From: SCHNABEL, CATHERINE; ZHANG, YI; ERLANDER, MARK

To: BIOTHERANOSTICS, INC.

Reel/Frame 056608/0046 →

Assignment of Assignor's Interest Jun 21, 2021

From: SGROI, DENNIS C.

To: THE GENERAL HOSPITAL

Reel/Frame 056608/0054 →

Security Interest Oct 12, 2021

From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED

To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT

Reel/Frame 057787/0526 →

Security Interest Apr 8, 2026

From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION

To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT

Reel/Frame 075462/0440 →